Literature DB >> 19664691

Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase.

Matthew S Macauley1, David J Vocadlo.   

Abstract

The O-GlcNAc modification is found on many nucleocytoplasmic proteins. The dynamic nature of O-GlcNAc, which in some ways is reminiscent of phosphorylation, has enabled investigators to modulate the stoichiometry of O-GlcNAc on proteins in order to study its function. Although several genetic and pharmacological methods for manipulating O-GlcNAc levels have been described, one of the most direct approaches of increasing global O-GlcNAc levels is by using small-molecule inhibitors of O-GlcNAcase (OGA). As the interest in increasing O-GlcNAc levels has grown, so too has the number of OGA inhibitors. This review provides an overview of the available methods of increasing O-GlcNAc levels, with a special emphasis on inhibition of OGA by small molecules. Known inhibitors of OGA are discussed with particular attention on those most suitable for cell-based biological studies. Several examples in which OGA inhibitors have been used to study the functional role of the O-GlcNAc modification in biological systems are discussed, highlighting the pros and cons of different inhibitors. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664691     DOI: 10.1016/j.bbagen.2009.07.028

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

1.  Chondroprotective effects of 4-methylumbelliferone and hyaluronan synthase-2 overexpression involve changes in chondrocyte energy metabolism.

Authors:  Kenya Terabe; Yoshifumi Ohashi; Saho Tsuchiya; Shinya Ishizuka; Cheryl B Knudson; Warren Knudson
Journal:  J Biol Chem       Date:  2019-10-16       Impact factor: 5.157

2.  A genetic model to study O-GlcNAc cycling in immortalized mouse embryonic fibroblasts.

Authors:  Melissa M St Amand; Michelle R Bond; Julia Riedy; Marcella Comly; Joseph Shiloach; John A Hanover
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

3.  Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode.

Authors:  Baobin Li; Hao Li; Lei Lu; Jiaoyang Jiang
Journal:  Nat Struct Mol Biol       Date:  2017-03-20       Impact factor: 15.369

4.  Recognition of diazirine-modified O-GlcNAc by human O-GlcNAcase.

Authors:  Andrea C Rodriguez; Jennifer J Kohler
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

5.  Glucosamine Modulates T Cell Differentiation through Down-regulating N-Linked Glycosylation of CD25.

Authors:  Ming-Wei Chien; Ming-Hong Lin; Shing-Hwa Huang; Shin-Huei Fu; Chao-Yuan Hsu; B Lin-Ju Yen; Jiann-Torng Chen; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

Review 6.  The emerging link between O-GlcNAc and Alzheimer disease.

Authors:  Yanping Zhu; Xiaoyang Shan; Scott A Yuzwa; David J Vocadlo
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

Review 7.  The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.

Authors:  Richard D Semba; Hu Huang; Gerard A Lutty; Jennifer E Van Eyk; Gerald W Hart
Journal:  Proteomics Clin Appl       Date:  2014-02-19       Impact factor: 3.494

Review 8.  Chemical approaches to study O-GlcNAcylation.

Authors:  Partha S Banerjee; Gerald W Hart; Jin Won Cho
Journal:  Chem Soc Rev       Date:  2012-12-18       Impact factor: 54.564

9.  Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis.

Authors:  Matthew S Macauley; Xiaoyang Shan; Scott A Yuzwa; Tracey M Gloster; David J Vocadlo
Journal:  Chem Biol       Date:  2010-09-24

10.  Human RNA Polymerase II Promoter Recruitment in Vitro Is Regulated by O-Linked N-Acetylglucosaminyltransferase (OGT).

Authors:  Brian A Lewis; Alma L Burlingame; Samuel A Myers
Journal:  J Biol Chem       Date:  2016-04-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.